NVCT Past Earnings image   This NVCT past earnings page last updated 5/9/2024
NVCT Past Earnings
PeriodPast Earnings DateGAAP
Q1 20245/7/2024-0.250
Q4 20233/5/2024-0.410
Q3 202311/8/2023-0.370
Q2 20238/9/2023-0.380
Q1 20235/10/2023-0.270
Q4 20223/7/2023-0.480
Q3 202211/8/2022-0.420
Q2 20228/5/2022-0.280
Q1 20225/10/2022-0.320
NVCT Past Revenue
PeriodPast Earnings DateGAAP
Q1 20245/7/2024NA
Q4 20233/5/2024NA
Q3 202311/8/2023NA
Q2 20238/9/2023NA
Q1 20235/10/2023NA
Q4 20223/7/2023NA
Q3 202211/8/2022NA
Q2 20228/5/2022NA
Q1 20225/10/2022NA
Quotes delayed 20 minutes

Email EnvelopeFree NVCT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Nuvectis Pharma (NVCT) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

NVIV Past Earnings
NVNO Past Earnings
NVOS Past Earnings
NVRO Past Earnings
NVST Past Earnings
NVTA Past Earnings
NXTC Past Earnings
OCGN Past Earnings
OCUL Past Earnings
OCUP Past Earnings

NVCT Past Earnings Q&A

What was the best and worst NVCT past earnings results?
For Nuvectis Pharma, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest NVCT past earnings result in our data set was -0.250/share posted in Q1 2024, while the lowest was in Q4 2022 when NVCT posted -0.480/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q1 2024 when NVCT reported NA in revenue, while the quarter with the lowest revenue in our data set was Q1 2024 at NA of revenue.

  Suggested answer: There are 9 NVCT past earnings results in our data set.

On this page we presented the NVCT past earnings date information for Nuvectis Pharma. Reviewing that NVCT Past Earnings for the company, we see that the highest past earnings result in our data set was in Q1 2024, when NVCT posted gaap of -0.250/share. Meanwhile the lowest NVCT past earnings result was in Q4 2022, when NVCT posted gaap of -0.480/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2024 when NVCT reported NA in revenue, while the smallest revenue quarter was Q1 2024 when NVCT reported NA in revenue.

Any self directed investor doing their due diligence on NVCT or any other given stock can benefit from researching all of the Nuvectis Pharma past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Nuvectis Pharma past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for NVCT. Thanks for visiting, and the next time you need to research NVCT past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Top Ten Hedge Funds Holding DIAP, QQXT Historical Stock Prices, GSHT market cap history.


NVCT Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.